CoChat
Sign Up
Cited by 254Dementia and Cognitive Impairment ResearchHallucinations in medical conditionsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Incidence of and risk factors for hallucinations and delusions in patients with probable AD

Paulsen, J.S., Salmon, D.P., Thal, L.J., Romero, R., Weisstein–Jenkins, C., Galasko, D., Hofstetter, C.R., Thomas, R., Grant, I., Jeste, D.V.·2000·Neurology
DOI 10.1212/wnl.54.10.1965
Open this paper in CoChat — free account

Abstract

OBJECTIVE: To examine the incidence of and risk factors for hallucinations and delusions associated with patients clinically diagnosed with probable AD. BACKGROUND: Estimates of the incidence of psychosis in AD range widely from 10% to 75%. The risk factors for psychosis of AD are not known, although multiple studies indicate that AD patients with psychosis demonstrate greater cognitive and functional impairment. METHODS: The authors conducted psychiatric evaluations of 329 patients with probable AD from the University of California at San Diego Alzheimer's Disease Research Center to determine the incidence of hallucinations and delusions. They examined data from annual clinical and neuropsychological evaluations to determine whether there were specific risk factors for the development of hallucinations and delusions. RESULTS: Using Cox survival analyses, the cumulative incidence of hallucinations and delusions was 20.1% at 1 year, 36.1% at 2, 49.5% at 3, and 51.3% at 4 years. Parkinsonian gait, bradyphrenia, exaggerated general cognitive decline, and exaggerated semantic memory decline were significant predictors. Age, education, and gender were not significant predictors. CONCLUSIONS: The authors found a relatively high incidence of hallucinations and delusions in patients diagnosed with probable AD and suggest that specific neurologic signs, cognitive abilities, and accelerated decline may be predictive markers for their occurrence.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.54.10.1965

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 48 references

Research works printed but not linked: 2

  1. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington DC:American Psychiatric Press 1987.
  2. Salmon DP Butters N. Neuropsychological assessment of dementia in the elderly. In: Katzman R Rowe JW eds. Principles of geriatric neurology. Philadelphia:FA Davis; 1992:144–163.

Cited by

Sorted by citations

Items 101–200 of 254

Related

See all

Metadata

Authors
Paulsen, J. S., Salmon, D. P., Thal, L. J., Romero, R., Weisstein–Jenkins, C., Galasko, D., Hofstetter, C. R., Thomas, R., Grant, I., & Jeste, D. V.
Affiliations
  • University of Iowa (US)
  • From the Departments of Psychiatry and Neurology (Dr. Paulsen)University of Iowa, Iowa City; Departments of Psychiatry (Drs. Salmon, Grant, Jeste, and R. Romero) and Neurosciences (Drs. Salmon, Thal, Weisstein-Jenkins, Galasko, Hofstetter, Thomas, and Jeste), University of California at San Diego School of Medicine; and the San Diego Department of Veterans Affairs Medical Center (Drs. Galasko, Grant, and Jeste).
ORCID
Venue
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2000-05-23
Volume
54
Issue
10
Pages
1965-1971
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
DOI
10.1212/wnl.54.10.1965
OpenAlex
W2144373877
Cited by
254
References
48
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 10 · 2019: 7 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 10 · 2014: 14 · 2013: 13 · 2012: 10
FWCI
12.40
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (AG05131, P50AG005131, AG 12963, R01AG012963, AG-05561)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, hallucinations, delusions, psychosis, incidence, risk factors, parkinsonian gait, bradyphrenia, cognitive decline, prodromal Alzheimer's disease
MeSH terms
Alzheimer Disease, Delusions, Frontal Lobe, Hallucinations, Humans, Mental Status Schedule, Neuropsychological Tests, Prognosis, Psychotic Disorders, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review